Track record · closed signal

UiPath Inc. (PATH) — closed signal from November 11, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on February 9, 2026.

Predicted vs. what happened

PATH price · publication thesis → realized outcomesplit-adjusted

$14.00 – $14.40Entry zone — fair-value band

$14.31Published — price the day we called it

$17.74Target — the price the thesis aimed for

$19.84Peak — highest point inside the window, not a realized return

$13.00Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 23 days.

Peak price

$19.84

peak on December 8, 2025 — not a realized return

Peak gain

+38.6%

peak, from the publication price

Window close

$13.00

end-of-window price, context only

Days to target

Window

November 11, 2025 – February 9, 2026

The thesis — published November 11, 2025

Predicted growth

+24%

over the measurement window

Target price

$17.74

the price the thesis aimed for

Entry zone

$14.00 – $14.40

the fair-value band we waited for

Price at publication

$14.31

published November 11, 2025

Confidence

61%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

UiPath's stock has fallen hard and may be due for a short-term rebound. Many investors look washed out, which sometimes marks a turning point. The company is refocusing on AI tools that manage software bots, and yearly subscription sales grew 11%, which helps the recovery story. This is a short, tactical idea: if results steady and existing customers keep spending, the price could reset higher in the next 0-3 months.

Primary drivers

Extremely sold-off conditions suggest sellers may be nearly exhausted now.
Investor mood is very negative, with heavier trading than usual recently.
Shifting to AI helpers; yearly subscription revenue rose 11% this year.
Price trend looks weak, so keep downside risk small and exits disciplined.

How it played out

PATH: target reached in 23 days

On 2025-11-11, Lyra published a short-term PATH thesis at $14.31. It expected 24% growth over 0-3 months, with a target of $17.74. The thesis pointed to extremely sold-off conditions, very negative investor mood, heavier trading than usual, a shift toward artificial intelligence helpers, and yearly subscription revenue that rose 11%.

Inside the window, PATH reached the target. The stock peaked at $19.84 on 2025-12-08, 23 days after publication, with a 38.6% peak gain. It later gave back the move and ended the window at $13. The thesis played out on the measured target, even though the close was below the publication price.

What happened during the window

On 2025-12-05, UiPath joined Veeva's partner program for application testing and validation. On 2025-12-24, S&P Dow Jones Indices said UiPath would join the S&P MidCap 400 before trading opened that Friday.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All PATH signals